AC
ICPT

Antara Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Antara Capital’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-75,000
Closed -$1.85M – 133
2020
Q4 		$1.85M Buy
+75,000
New +$2.49M 0.38% 25
2020
Q1 		– Sell
-20,000
Closed -$2.48M – 57
2019
Q4 		$2.48M Sell
20,000
-22,500
-53% -$2.01M 0.5% 39
2019
Q3 		$2.82M Sell
42,500
-35,500
-46% -$2.38M 1.31% 15
2019
Q2 		$6.21M Buy
78,000
+54,000
+225% +$4.83M 1.35% 20
2019
Q1 		$2.68M Buy
+24,000
New +$2.62M 0.76% 33

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Antara Capital's ICPT Position: Q1 2021 in Review

Antara Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 83,926 shares — an estimated $2.07M sold.

Antara Capital first reported a position in ICPT in Q4 2019 and held it in 2 quarters. The position peaked at $2.94M in Q4 2019. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

  • Antara Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Antara Capital sold 83,926 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $2.07M.
  • Antara Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2019 and held it in 2 quarters.
  • Antara Capital's Intercept Pharmaceuticals, Inc. position peaked at $2.94M in Q4 2019.
  • 151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Antara Capital's 13F filing for Q1 2021, filed 17 May 2021.